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Abstract: The separation of enantiomers is of great importance due to their possible differences
in therapeutic properties. Preferential crystallization in various configurations of coupled batch
crystallizers is used as an attractive means to separate the conglomerate-forming enantiomers from
racemic mixtures. However, the productivity of such batch processes can be limited by the nucleation
of the counter enantiomer and consumption of the supersaturation. In this work, a recently proposed
process configuration, which uses coupled mixed suspension mixed product removal (MSMPR)
with liquid phase exchange, is investigated by simulation studies. A detailed study on the effect of
process parameters (e.g., feed flow rate, seed mass, and liquid phase exchange) on the productivity
and yield of the coupled MSMPR has been presented. Moreover, a comparison of various coupled
crystallizer configurations is carried out. It is shown through simulation studies that the productivity
of the enantiomeric separation can be significantly improved compared to the previously proposed
batch modes when the continuous configuration is used. The effect of nucleation kinetic parameters
on the performances of various crystallizer configurations is studied as well. A set of coupled
population balance equations (PBEs) was used to describe the evolution of the crystal phase of the
both enantiomers in each vessel. These equations were solved numerically using the quadrature
method of moments. The insights obtained in this study will be useful in the process design of
coupled crystallizer systems.
Keywords: chiral resolution; coupled crystallizer; crystallization modelling; enantioseparation; MSMPR
1. Introduction
Enantiomers are the result of the chirality or handedness of molecules which are the
non-superimposable mirror images of each other. Enantiomers are widely found in organic compounds
and their separation is a major concern in the modern pharmaceutical, food, and agricultural industries.
Separation of the enantiomorphs is particularly important in pharmaceutical industry, since very often
one of the enantiomers exhibits the intended therapeutic activity while the other is inert. Moreover,
in some cases the counter enantiomer can cause toxicity or adverse effects. For example, S(−)-fluoxetine
shows remarkable therapeutic effects in preventing migraines, while the racemic (equimolar mixture
of both enantiomers) drug (the antidepressant Prozac) has no effect [1]. Thalidomide consisting of S(−)
and R(+) enantiomers can interconvert under physiological conditions. R(+)-thalidomide seems to
act as a sedative while S(−)-thalidomide and its derivatives are reported to be teratogenic (causing
malformations of an embryo or fetus) [2]. Thus, it is demanded by the regulating authorities that
the chiral drugs are administered in an optically pure form [3]. This stringent regulatory policy has
Pharmaceutics 2017, 9, 55; doi:10.3390/pharmaceutics9040055 www.mdpi.com/journal/pharmaceutics
Pharmaceutics 2017, 9, 55 2 of 19
intensified efforts in industrial and academic research to develop processes that are able to produce
pure enantiomers.
There are two major strategies to obtain a single pure enantiomer: (1) the ‘chiral approach’ is based
on developing the asymmetric synthesis of the selected enantiomer; and (2) the ‘racemic approach’
is based on the separation of the mixture of two enantiomers [4]. Although ideal, the asymmetric
synthesis route can be time-consuming to develop. Moreover, the number of highly selective reactions
that supply pure enantiomers on an industrially relevant scale is still limited [4]. Conversely, the latter
is the most widely used approach to produce preferred enantiomers, since the enantiomers are
typically readily available in racemic composition. Various means available for the resolution of
enantiomers include classical chiral separation techniques such as preferential crystallization [5–13],
Viedma ripening [14–16], chromatography [1,17–19], and membrane separation [20,21]. Some hybrid
techniques coupling chromatography and crystallization are also proposed [22–24]. A more detailed
review of the various techniques can be found in Lorenz and Seidel-Morgenstern [4].
Among various means, preferential crystallization is an attractive and efficient way to separate
the racemic mixtures since no auxiliaries and reagents other than solvent are needed [10]. However,
preferential crystallization can only be used for conglomerate-forming systems (which make up 10%
of the available enantiomers [5]). In such systems the stable crystalline phases consist of either the
pure S enantiomer or pure R enantiomer. This is in contrast to the racemic compound-forming system
where there is an additional racemic phase consisting of equal amounts of R and S enantiomers.
Crystallization can be carried out in standard equipment readily available in pharmaceutical and
fine chemical industries. Manufacturing methods of the enantiomorphic drug are still dominated
by crystallization [4]. In preferential crystallization, the process is operated in the metastable
zone, i.e., a region in the phase diagram where the solution is thermodynamically unstable but
kinetically inhibited based on different initial surface areas [25]. Addition of the homochiral
seeds at this stage favours the crystallization of a particular enantiomer which can be harvested
as solid phase thus providing enantioseparation. In particular, it has been shown that batch
coupled preferential crystallizer (CPC) with liquid exchange can be used as an attractive means of
enantioseparation [9,10,25]. However, the productivity of the regular CPC is limited by the depletion
of the supersaturation. Moreover, it has been shown that a variant of the CPC configuration, coupled
preferential crystallization-dissolution (CPC-D), can increase the productivity [11,26]. This alternative
configuration is based on coupling preferential crystallization in one vessel, with selective dissolution
of the solid racemate in the other. However, in this process configuration, one needs to collect the
pure crystals within a window of time determined by the appearance of the counter enantiomer in the
crystallization vessel and complete dissolution of one enantiomer in the dissolution vessel [11,26].
Recently, a continuous version of the CPC configuration was proposed [27–29]. This configuration
utilizes two mixed suspension mixed product removal (MSMPR) crystallizers which are coupled
through solid free liquid phase exchange, henceforth referred as CPC-MSMPR. Theoretical and
experimental investigations demonstrate the efficiency and increased productivity of the CPC-MSMPR
configuration [27,28,30]. However, a thorough comparison of the various coupled crystallizer
configurations for the separation of enantiomorphs has not been performed. The objective of this study
is to compare the performance of CPC, CPC-D, and CPC-MSMPR in terms of productivity and yield.
Furthermore, the effect of various process parameters (e.g., feed flow rate, seed mass, and liquid phase
exchange rate) on the productivity and yield of the CPC-MSMPR is studied. The details of the coupled
crystallizer configurations are discussed next.
2. Coupled Preferential Crystallizer Configurations
2.1. CPC-MSMPR Configuration
As shown in Figure 1a, the process configuration involves two mixed suspension mixed product
removal (MSMPR) crystallizers maintained at a temperature lower than the saturation temperature
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and coupled through liquid phase exchange. The MSMPR crystallizers are mixed well enough to
ensure uniform conditions. The process starts with a supersaturated racemic solution in both the
vessels. Slurry containing racemic solution and seeds of the opposite homochiral enantiomers is
continuously fed into two different vessels. The continuous supply of seeds can be maintained by
ultrasonic comminution of crystals, withdrawn from the bottom of the MSMPR crystallizers [12].
This slurry addition allows growth and nucleation of the opposite enantiomers in the different MSMPR
crystallizers while almost completely suppressing the nucleation of the counter enantiomers. The equal
volume of slurry will be continuously taken out of each crystallizer as a product stream in order to
maintain the same slurry volume within the crystallizers. Due to selective crystallization in each vessel,
e.g., E1 in Tank 1 and E2 in Tank 2, the concentration of the preferred enantiomer in the liquid phase
decreases. The liquid phase exchange between the vessels makes up this depletion of the preferred
enantiomer to some extent while reducing the concentration of the counter enantiomer, and thus helps
to prevent the primary nucleation of counter enantiomer.
2.2. CPC Configuration
This configuration, shown in Figure 1b, is the batch version of the CPC-MSMPR, i.e., there are
no continuous feed and product removals. The process starts when homochiral seeds are introduced
in the vessels containing racemic solution at a temperature lower than the saturation temperature
(i.e., in the metastable zone). As a result, preferential crystallization of seeded enantiomers takes place
in each tank. The solid free liquid phases are exchanged between the two vessels. The process can be
run until the supersaturation is depleted or the counter enantiomorph appears in any vessel due to
nucleation. The product crystals are obtained at the end of the batch.
2.3. CPC-D Configuration
This configuration is run in batch mode. However, the two tanks are maintained at two different
temperatures as shown in Figure 1c. At first, both the tanks are fed with racemic liquid solution.
The temperature of Tank 1 is lower than the saturation temperature but within the metastable zone.
Tank 2 is maintained at the saturation temperature and a racemic solid mixture is added to Tank 2.
The process begins when Tank 1 is seeded with enantiopure seeds, E1. Since the liquid phase is
supersaturated in Tank 1, preferential crystallization of the seeded enantiomorph E1 takes place and
solid mass increases. Due to the exchange of solid free liquid phase, the solution in Tank 2 becomes
under-saturated with respect to E1. This leads to the selective dissolution of E1 in Tank 2. As a result,
concentration of E1 in Tank 2 increases until saturation concentration is reached. The liquid phase
exchange also ensures that depletion of E1 in Tank 1 is partially compensated. The counter enantiomer
E2 remains in solid form in Tank 2 as the concentration of E2 is not affected by the crystallization of
E1. The process can be run until primary nucleation for E2 is detected in Tank 1 or dissolution of E1 is
complete in Tank 2.
In this study, the preferential crystallization of amino acid threonine dissolved in water is used as
a model system. The process is modeled using widely used population balance equation (PBE) [28,30]
coupled with the mass balance equation. The required growth and nucleation kinetic parameters are
experimentally estimated and validated [10,11], and are presented in tabular form in the Appendix.
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Figure 1. (a) Coupled preferential crystallization in MSMPR crystallizers (CPC-MSMPR), where each
vessel initially containing supersaturated racemic solution is continuously fed with a slurry containing
the seed of the specific enatiomorph. Exchange of liquid phase makes use of the depletion of the counter
enantiomer in the other vessel; (b) The coupled preferential crystallizer (CPC) configuration, which is
similar to CPC-MSMPR except that there is no continuous feed and product removal; (c) The coupled
preferential crystallization-dissolution (CPC-D) configuration, which is similar to CPC except that
Tank 2 (seeded with racemic solid) is maintained at saturation temperature so that dissolution of
counter enantiomorph E1 takes place.
3. Model of the Coupled Crystallization Process
The model presented here is based on Eicke et al. [11] and has been verified experimentally. In a
crystallizer, crystals are dispersed in a continuous phase or solution phase. The population balance
equation (PBE) is used to describe the evolution of the crystal size distribution (CSD) in MSMPR
as follows
∂ f (j)k
∂t
+
∂
∂L
(R(j)k f
(j)
k ) =
q
V
( f (j)k, f eed − f
(j)
k ); j ∈ {T1, T2}, k ∈ {E1, E2}, (1)
where f (j)k is the number density or CSD of enantiomer k in Tank j where T1 and T2 stand for Tank 1
and Tank 2, respectively, L is the characteristic size of the crystals, R(j)k is either the size-dependent
growth rate, G(j)k , or dissolution rate, D
(j)
k , depending on the degree of supersaturation, S
(j)
k
R(j)k =

G(j)k for S
(j)
k > 1,
0 for S(j)k = 0,
D(j)k for S
(j)
k < 1,
j ∈ {T1, T2}, k ∈ {E1, E2}, (2)
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q is the volumetric flow rate for the feed (q = 0 for batch configuration) and product stream, and V is
the volume of the crystallizer. The necessary initial and boundary conditions required are
f (j)k (L, t)|t=0 = f
(j)
k,seed(L, t), (3)
f (j)k (L, t)|L=L0 =

B(j)k
G(j)k
for S(j)k ≥ 1,
0 for S(j)k < 1,
j ∈ {T1, T2}, k ∈ {E1, E2}, (4)
where B(j)k is the rate of nucleation which is assumed to be taking place at size L0. It is further assumed
that the particles vanish at size L0 during dissolution. In this technique, both the MSMPR crystallizers
are fed with one pure enantiomer of an opposite kind
f (T1)k, f eed =
 f
(T1)
E1,seed
for k = E1,
0 for k = E2,
(5)
f (T2)k, f eed =
0 for k = E1,f (T2)E2,seed for k = E2, (6)
The measured CSDs of threonine-controlled samples (sample size >500 particles) can be
approximated by a log-normal distribution with sufficient accuracy in terms of the characteristic length
f (j)k,seed = A
(j)
k,seed
1√
2piσ(j)ln,kL
exp
−12
ln
 L
L(j)mean,k
 1
σ
(j)
ln,k
2
 . (7)
The parameter A(j)k,seed is the ratio of the mass of seeds and the mass of the control sample given by
A(j)k,seed =
m(j)k,seed
kvρs
∫ ∞
0 L
3 f (j)k,csdL
=
m(j)k,seed
kvρsµ
(j)
3,k,cs
, (8)
where f (j)k,cs and µ
(j)
3,k,cs are the CSD and third moment of the control sample, respectively.
In order to track the liquid phase concentration the mass balance has to be considered as follows
dm(j)k,L
dt
= Fexρ
(j∗)
L w
(j∗)
k,L − Fexρ
(j)
L w
(j)
k,L − 3kvρs
∫ ∞
0
L2R(j)k f
(j)
k dL
+qρ(j)L, f eedw
(j)
k,L, f eed − qρ
(j)
L w
(j)
k,L, (9)
j∗ 6= j with j, j∗ ∈ {T1, T2}
where m(j)k,L is the mass of enantiomorph k at the liquid phase in Tank j, Fex is the volumetric liquid
phase exchange rate, ρL is the current density of the liquid phase, and w
(j)
k,L is the mass fraction of each
component defined as
w(j)k,L =
m(j)k,L
∑k m
(j)
k,L + mH2O
. (10)
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The mass of water mH2O is assumed to be constant in both the tanks. The density of the liquid
phase can be calculated by an empirical formula taking into account the composition as follows
ρ
(j)
L (t) = ρ
(j)
H2O
(T(j)) + K3∑
k
w(j)L (t), (11)
ρ
(j)
H2O
(T(j)) =
1
K1 + K2(T(j))2
, (12)
where ρ(j)H2O denotes the density of water at a given temperature and K1, K2, and K3 are constants.
The supersaturation driving force is expressed as a ratio of the present mass fraction and the
equilibrium mass fraction as
S(j)k (t) =
w(j)k,L(t)
w(j)k,L,eq(T
(j))
. (13)
The solubility of the DL-threonine in water for a relatively wide temperature and composition
range is given by the following expression
w(j)k,L,eq(T
(j)) = a2sol
[
w(j)k∗,L(t)
]2
+ a1solw
(j)
k∗,L(t) + msolT + bsol , (14)
k∗ 6= k with k, k∗ ∈ {E1, E2}. (15)
The empirical size-dependent growth rate expression is found to be as follows
G(j)k (t, L) = k
(j)
g (T(j))
[
S(j)k (t)− 1
]g
(1+ aASLL)γ, (16)
where k(j)g is the temperature-dependent rate constant
k(j)g (T(j)) = kg,e f f exp
(
− EA,g
RgT(j)
)
, (17)
where the pre-exponential factor kg,e f f , is a constant model parameter. On the other hand, the dissolution
rate in undersaturated solution is found to be
D(j)k (t, L) = kdiss [S− 1] . (18)
New particles are born in a supersaturated solution due to primary and secondary nucleation.
The secondary nucleation of enantiomer k takes place predominantly if crystals of that enantiomer are
already present. It can be expressed as
B(j)sec(t) = k
(j)
b,sec(T)
[
S(j)k − 1
]b,sec [
µ
(j)
3,k(t)
]nµ3
, (19)
k(j)b,sec(T) = kb,sec,e f f exp
(
− EA,b
RgT(j)
)
, (20)
where µ3,k is the third moment of the enantiomer k. The temperature-dependent rate constant kb,sec is
expressed by an Arrhenius-type equation. The primary nucleation takes place in the clear solution
B(j)k,prim = knuc
[
S(j)k − 1
]bnuc
Ψ(tind), (21)
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where induction time tind, defined as the time difference between reaching the initial degree of
supersaturation and the point of first measured concentration decrease in the liquid phase under
seeded conditions, is introduced that describes the experimental observations reasonably well [11].
Ψ is the sigmoid function where the steepness is determined by the second parameter φ
Ψ(tind) =
1
2
+
1
pi
arctan[φ(t− tind)]. (22)
All the required parameters are listed in Table A1 in the Appendix. The resulting PBEs are solved
numerically for the moments of distribution using quadrature method of moments (QMOM) [31].
QMOM transforms the PBEs to a set of ordinary differential equations (ODEs) describing the evolution
of moments of distribution. QMOM has been chosen for solving the PBEs as the method of moments
(MOM) is not able close the moment chain for this system, a common issue encountered when growth
rate is a nonlinear function of crystal size. The resulting set of ODEs coupled with the mass balance
equation are solved in Matlab using standard ODE solvers.
4. Results and Discussion
4.1. DL-threonine/H2O as Model System
The well-investigated DL-threonine/H2O is chosen as a model system for these studies [11].
The kinetic parameters for DL-threonine are identical for both the enantiomers. For the CPC-MSMPR
configuration, two MSMPR vessels of volume V = 0.45 L are connected together with exchange of
liquid phase. The vessels contain racemic liquid phase at 36 ◦C (Tsat = 45 ◦C) with homochiral solid
phase. The feed streams with the same conditions are fed to each vessel. In order to the keep slurry
volume constant, the same amount of slurry as the feed stream is taken out of the vessels as the product
stream. The results obtained from CPC-MSMPR are compared with the conventional CPC and CPC-D
configurations. The condition for CPC configuration is similar to CPC-MSMPR except that there are no
feed and product streams. For CPC-D, the condition for the crystallization vessel (Tank 1) is same as
CPC. However, the dissolution vessel (Tank 2) is at saturation temperature Tsat = 45 ◦C and it contains
a racemic solid phase. The process conditions are summarized in Table 1.
Table 1. Process conditions used in simulation studies for coupled preferential crystallization in
MSMPR crystallizers (CPC-MSMPR), coupled preferential crystallization (CPC) in batch mode and
coupled preferential crystallization-dissolution (CPC-D) in batch mode.
CPC-MSMPR CPC CPC-D
Variable Tank 1 Tank 2 Tank 1 Tank 2 Tank 1 Tank 2
Liquid phase mrac,L 97.48 g 97.48 g 97.48 g 97.48 g 97.48 g 97.48 gmH2O 369.83 g 369.83 g 369.83 g 369.83 g 369.83 g 369.83 g
Solid phase mE1,S (L-threonine) 2.00 g − 2.00 g − 2.00 g 35.00 gmE2,S (D-threonine) − 2.00 g − 2.00 g − 35.00 g
Temperatures T(T1)cryst; T
(T2)
cryst 36
◦C 36 ◦C 36 ◦C 36 ◦C 36 ◦C 45 ◦C
Exchange rate Fex 80 mL min−1 80 mL min−1 80 mL min−1
Feed rate q 80 mL min−1 80 mL min−1 − − − −
Removal rate q 80 mL min−1 80 mL min−1 − − − −
Eicke et al. [11] have shown the ability of the model to predict the preferential crystallization
process within the temperature range considered in these studies. Here, we first investigate the
evolution of the solute mass in the liquid and solid phases for all the process configurations. We also
investigate and compare the performance of each configuration in terms of productivity and yield.
The productivity of the CPC-MSMPR is defined as
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Pr(j)k =
(
m˙(j)k,S,prod − m˙
(j)
k,S, f eed
)
ee(j)S , (23)
k =
{
E1(L-threonine) for j = T1
E2(D-threonine) for j = T2
(24)
where m˙(j)k,S,prod and m˙
(j)
k,S, f eed are the solid crystal mass flow rates in the product stream and feed stream,
respectively, and ee(j)S is the enantiomeric excess, which is used as a weighting factor in the definition
of productivity so that purity of the products is taken into account. eeS is defined as
ee(j)S =
∣∣∣m(j)k,S −m(j)k∗,S∣∣∣
m(j)k,S + m
(j)
k∗,S
× 100%, (25)
k∗ 6= k with k, k∗ ∈ {E1, E2},
where m(j)k,S is the mass of the solid phase of enantiomorph k in the crystallizer. For the CPC and CPC-D
configurations the equivalent productivity for comparison is defined as
Pr(j)k =
m(j)k,S −m(j)k,seed
t
 ee(j)S . (26)
It is to be noted that for the CPC-D configuration, mk,seed = 0 for j = T2, as seed is only used in
the crystallization tank. In the dissolution tank, a racemic solid is used which is not considered as
investment while calculating productivity. The another performance indicator used is the yield of the
process which is defined for the CPC-MSMPR configuration as
Y(j)k =
 m˙(j)k,L, f eed − m˙(j)k,L
m˙(j)k,L, f eed
 ee(j)S , (27)
where m˙(j)k,L, f eed and m˙
(j)
k,L, f eed are mass flow rates of the enantiomorph k in the liquid phase in the feed
stream and in the product stream, respectively. For the CPC and CPC-D configurations, the yield is
defined as follows
Y(j)k =
m(j)k,L, f eed + mk,R −m(j)k,L
m(j)k,L, f eed + mk,R
 ee(j)S , (28)
where mk,R is the mass of the enantiomorph k in the racemate. mk,R is nonzero only for Tank 2 in the
CPC-D configuration.
4.2. Liquid and Solid Phase Mass Evolution
The simulation results for various process configurations are presented in this section. In Figure 2,
the results for CPC-MSMPR are presented where the feed and product removal rate used is
80 mL min−1. The solid mass of pure enantiomer increases from seed mass of 2 g to the steady
state value of 3.7 g in both the tanks. The nucleation of the counter enantiomer is almost completely
suppressed. The racemic liquid phase starts with equal amount of both the eanatiomers. In a time
of about 0.5 h, the mass of the enantiomers in the liquid phase reaches a steady state of two different
values. The enantiomer which is being enriched in the solid phase has a lower steady sate mass in the
liquid phase. The mass evolution profiles for the CPC configuration, shown in Figure 3, is similar to
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the CPC-MSMPR except the steady sate mass in the liquid phases is the same for both the enantiomers.
This is because there are no feed and product streams in this configuration and thus the sufficiently
high exchange of liquid phases ensures that the mass of the two enantiomers is the same in the liquid
phases. In Figure 4, the mass evolution for CPC-D is presented. The mass of E1 in the solid phase
of Tank 1 increases with time due to nucleation and growth until it reaches the steady state value
at around 2.5 h. As a result, mass in the liquid phase for E1 in Tank 1 decreases which is partially
compensated due to dissolution of E1 in Tank 2. The E1 solid in Tank 2 completely dissolves at about
1.5 h, and this results in a sudden increase of depletion rate of E1 in the liquid phases at Tank 1 and
Tank 2. On the other hand, E2 appears in Tank 1 due to primary nucleation after about 2.5 h which
results in a decrease of E2 concentration in the liquid phase in Tank 1. The rate of depletion of E2 in
the liquid phases further increases in both the tanks at about 6 h when E2 in solid phase in Tank 2
dissolves completely.
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Figure 2. Evolution of mass in liquid and solid phases for the coupled preferential crystallization in
MSMPR crystallizers (CPC-MSMPR).
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(CPC) configuration.
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4.3. Effect of Feed Flow Rate on CPC-MSMPR Productivity and Yield
The effect of feed flow rates on productivity and yield is investigated first for the CPC-MSMPR
configuration. The simulation results for Tank 1 are presented in Figure 5. It is to be noted that due
to the identical kinetic parameters obtained for both the enantiomers and similar process conditions,
the productivity and yield in both the vessels are similar for CPC-MSMPR (and also for CPC)
configuration. As can be seen in Figure 5a, the system reaches steady state in about 1.5 h. The increment
of feed flow rate up to 80 mL min−1 increases the productivity to a certain level. A further increase
in feed flow is accompanied by a negligible increase in productivity. Another important feature in
Figure 5a is that the productivity sharply reduces to zero after about 5 h when the feed flow rate is
10 mL min−1. This occurs due to the fact that at low feed flow rates, the residence time of the slurry
increases and appearance of the counter enantiomer takes place due to nucleation. This eventually
reduces the purity of the crystal product under the specified value of eeS = 99%. The optimal feed flow
rate is related to the residence time of the seed crystals needed to grow by consuming supersaturation
in the MSMPR. Conversely, the yield of the process decreases as the feed flow rate increases as shown
in Figure 5b. This is because the increase of feed flow rate decreases the mean residence time and the
solution spends less time crystallizing in the crystallizer. Moreover, if the residence time is too long
(e.g., with feed flow rate of 10 mL min−1), the purity of the product crystals can be adversely affected
by the nucleation of the counter enantiomer. Like many other processes, a trade-off exists between the
productivity and yield for the CPC-MSMPR configuration. The feed flow rate of 80 mL min−1 is used
while comparing with other configurations as this flow rate provides high productivity. The low yield
can be compensated to some extent by recycling the product solution from the crystallizer to the feed
stream after racemization so that overall yield increases [32,33].
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Figure 5. Simulation results showing effect feed flow rate on the productivity and yield for the
coupled preferential crystallization in MSMPR crystallizers (CPC-MSMPR) (seed mass 2 g, liquid phase
exchange rate 80 mL min−1). (a) Increase in feed flow rate up to 80 mL min−1 causes an increase in
production to a certain level, beyond which no significant improvement in production is achieved;
(b) Yield of the process decreases while feed flow rate increases, as increase of feed flow rate reduces
the residence time of the solution (for legend please refer to (a)).
4.4. Effect of Liquid Phase Exchange Rate on CPC-MSMPR Productivity and Yield
The liquid phase exchange between the coupled crystallizers helps to compensate the depletion
of the preferred enantiomer concentration. The effects of liquid phase exchange rate on productivity
and yield are shown in Figure 6. The trends observed are similar to the effect of feed flow rate. As the
exchange rate increases, the productivity increases as it enhances the amount of product crystals in the
solid phase due to higher rate of crystallization. The return on increased exchange rate diminishes
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gradually. However, a higher exchange rate would also mean the depletion of the preferred enantiomer
in the liquid phase due to crystallization being compensated at a higher rate. The net effect observed is
the decrease in yield with the increase of exchange rate.
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Figure 6. Simulation results showing the effect of the liquid phase exchange rate on the productivity
and yield of the coupled preferential crystallization in MSMPR crystallizers (CPC-MSMPR) (feed flow
rate 80 mL min−1, seed mass 2 g). (a) Increase of liquid phase exchange increases productivity; (b) Yield
of the processes decreases while the feed flow rate increases, as an increase of the feed flow rate reduces
the residence time of the solution.
4.5. Effect of Seed Mass on CPC-MSMPR Productivity and Yield
Here, we investigate the effect of seed mass on the productivity and yield for the CPC-MSMPR
configuration. The simulation results are presented in Figure 7 where the seed mass starting from 1 g
is increased to 8 g. As can be seen, both the productivity and yield increase with the increase of seed
mass. This can be attributed to the fact that increased seed mass provides increased surface area for
the crystal growth. Thus, for the same residence time, more supersaturation will be consumed by the
seeds with larger surface area. This has beneficial effect on both the productivity and yield.
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Figure 7. Simulation results showing the effect of seed mass on the productivity and yield of the
coupled preferential crystallization in MSMPR crystallizers (CPC-MSMPR) (feed flow rate 80 mL min−1,
exchange rate 80 mL min−1). (a) Productivity increases with seed mass; (b) Yield increases with seed
mass (for legend please refer to (a)).
Pharmaceutics 2017, 9, 55 13 of 19
4.6. Productivity and Yield of CPC and CPC-D Configurations
In Figure 8, the effect of seed mass on the productivity and yield for the CPC batch configuration
is presented. The liquid exchange rate is kept at 80 mL min−1. Here the downtime (time needed to
prepare the vessel for the next batch) is assumed to be td = 1 h, and thus productivity and yield are
zero before 1 h. It can be seen that although after 1 h there are indications of a marginal increment
in the productivity and yield, soon the differences become less obvious and after about 3 h there are
hardly any differences. This observation is due to the fact that once the supersaturation is consumed at
the initial stages of the batch process, the effect of seed mass becomes insignificant as there is not much
driving force left. Similar observations were found when the effect of liquid phase exchange rate was
investigated (not presented here) for the CPC configuration, i.e., it has insignificant effect on the final
productivity and yield.
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Figure 8. Simulation results showing the effect of seed mass on the productivity and yield of the coupled
preferential crystallization (CPC) configuration (exchange rate 80 mL min−1). Final productivity and
yield are not affected by seed mass. (a) Productivity evolution; (b) Yield evolution.
Next, in Figure 9 we present the effect of racemate mass on the dissolution tank of the CPC-D
configuration. The downtime is taken to be 1 h. The racemate mass is varied from 20 g to 70 g
while keeping seed mass at 2 g and liquid phase exchange rate at 80 mL min−1. For each of these
considerations, two different curves are obtained in each vessel for both the productivity and yield,
since unlike the previous configurations, the process conditions are different in the two vessels in the
CPC-D configuration. The sharp changes in the curves are due to the purity requirement of the crystal
product which is set to eeS = 99%. In Tank 1, the productivity and yield suddenly change to zero
because at this time the purity (eeS) of the preferred enantiomer goes below 99% due to the nucleation
of the counter enantiomer. Conversely, the productivity and yield at Tank 2 suddenly jump from zero
to a certain value because the purity of the preferred enantiomer at that tank has just reached 99% due
to the dissolution of the counter enantiomer. Thus, in order to ensure the supply of the product crystals
from both the vessels, the CPC-D configuration should be harvested during the period enclosed by
the time when the product crystal with required purity appears in the dissolution vessel and the time
when the purity of the product crystals in the crystallization vessel goes below the required level, as
shown in Figure 9a. The productivity and yield increase with the increment of the racemic solid used.
However, this increment is accompanied by the decrease in the length of the time period available for
product crystal removal. Thus, there is a trade-off between the increase of productivity and the length
of harvest period. The effect of seed mass is also investigated (not reported here) and no significant
effect is found for the same reason explained for the CPC configuration.
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Figure 9. Simulation results showing effect of racemate mass on the productivity and yield of
coupled preferential crystallization-dissolution (CPC-D) configuration (seed mass 2 g, exchange rate
80 mL min−1). (a) Productivity for Tank 1 and Tank 2; (b) Yield for Tank 1 and Tank 2.
4.7. Comparison of Productivities and Yields for Various Configurations
In Figure 10, a comparison of all three configurations is shown in terms of productivity and
yield. In this comparison, the process parameters used are seed mass 8 g, feed flow rate 80 mL min−1,
and exchange rate 80 mL min−1, for which higher productivities are found in various configurations.
The amount of racemic solid used in Tank 2 for CPC-D configuration is 70 g, so that the productivity is
high and harvest period is long enough to collect the product crystals with ease.
As can be seen in this figure, the productivity of CPC-D is higher than in the CPC configuration.
This result is consistent with Eicke et al. [11]. The sharp decrease of productivity in Tank 1 at about
3.7 h is due to the appearance of the counter enantiomer resulting from nucleation. Conversely, the
sudden rise in productivity in Tank 2 at about 3 h indicates the dissolution of the counter enantiomer
(E1) in Tank 2 so that ees = 99%. In order to ensure that pure enantiomers can be achieved from both the
crystallizers of CPCD configuration, the window of time between the dissolution of counter enantiomer
in dissolution tank (ees = 99%) and the appearance of the counter enantiomer in the crystallization
tank (ees = 99%) should be long enough to allow collection of products. In some process conditions,
for example when the seed crystal surface area is not large enough to consume the supersaturation at a
given rate, primary nucleation of the counter enantiomer can occur at the crystallization tank before
the required dissolution of the counter enantiomer for ees = 99% (Eicke et al. [11]). Such phenomena
lead to the shrinkage of the harvest period to zero and this essentially means that pure enantiomers
can be collected from only one tank. In other words, such an operating condition will lead the process
to an unattractive region of operation. However, the other two configurations CPC and CPC-MSMPR
do not suffer from such limitations. This is due to the fact that both the enantiomers crystallize in
separate coupled vessels in CPC and CPC-MSMPR configurations which depletes the supersaturation
of the respective enantiomers.
In Figure 10, we can further see that the CPC-MSMPR configuration provides the highest
productivity. The increase of productivity found in CPC-MSMPR is almost two-fold compared to the
maximum productivity for CPC-D configuration and five-fold compared to the maximum productivity
for CPC. Due to the batch configuration, the productivities for CPC and CPC-D configurations are
limited by the consumption of the supersaturation which has no provisions to replenish from feed
streams. However, this is not the case for the CPC-MSMPR crystallizer where there is a steady supply
of racemic solution to the tanks. This also allows the CPC-MSMPR configuration to maintain the high
level of productivity and purity for about 8 h, indicating that the process has reached a steady state.
Thus, the superiority of the continuous configuration in terms of productivity as compared to the batch
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configurations has been shown by these simulation results for the system considered. Nonetheless,
as can be seen in Figure 10b, this high productivity comes at the cost of low yield. When it comes
to yield, CPC and CPC-D configurtions perform better than the CPC-MSMPR configuration. This
can be explained by considering the residence time for each configuration. Since the CPC-MSMPR
configuration has steady feed flow and product removal, the residence time for the slurry is much
shorter (5.64 min) as compared to the CPC and CPC-D configurations (8 h). As a result, the time
available for the seed crystals to grow is much shorter for CPC-MSMPR crystallizer and thus a lower
yield is obtained. One can choose an appropriate feed flow rate for CPC-MSMPR configuration by
balancing productivity and yield based on the priority. However, if there is a provision for recycling
the solution obtained from the product stream after filtering the product crystals and subsequent
racemization, the low yield of the CPC-MSMPR configuration can be compensated. The overall
yield that can be obtained with recycle is equivalent to that of the equilibrium batch process or even
greater [32]. However, the increase of yield by using recycle stream can be limited if there is a build-up
of impurities within the system [32].
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Figure 10. (a) Comparison of productivities for various process configurations. Process parameters
used are seed mass 8 g, feed flow rate rate 80 mL min−1, exchange rate 80 mL min−1, and racemate mass
70 g. The productivity for coupled preferential crystallization in MSMPR crystallizers (CPC-MSMPR)
is found to be the highest. The sudden rise and fall of productivities for the coupled preferential
crystallization-dissolution (CPC-D) configuration is due to the use of cut-off purity of eeS = 99%;
(b) Curves showing comparison of yields. The yield of CPC-MSMPR is the lowest. The relatively high
yield of CPC-D configuration in Tank 2 is due to the use large amount of racemic solid.
4.8. Effect of Nucleation Kinetics on the Performances of Various Configurations
In the previous sections, experimentally determined kinetic parameters for the DL-threonine-H2O
system were used in the simulation results. Here we investigate how the nucleation kinetic parameters
affect the performance of the various configurations. The secondary and primary nucleation rates
for this system are given by Equations (19) and (21), respectively. A scaling factor α is used to scale
the parameters k(j)b,sec and knuc appearing in those equations. For instance, when α = 1, we have the
original values of the parameters as shown in Table A1 and when α = 10, these two parameters are
increased ten-fold. This essentially means that with α = 10 the primary and secondary nucleation
rates are increased ten-fold in the same process condition. Such a study will be useful in predicting
process performance for systems with higher nucleation rates. The simulation results using various
values of α for the CPC-MSMPR configuration are shown in Figure 11a where the process parameters
used are seed mass 1 g, feed rate 80 mL min−1, and liquid phase exchange 80 mL min−1. As can be
seen, the productivities plummet to zero between 1 h and 3 h for α = 10, 100, 500 as it significantly
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increases the nucleation rate for both the preferred and counter enantiomers, resulting in the product
purity dropping below the cut-off purity of eeS = 99%. The higher the nucleation rate, the sooner
the purity falls below the cut-off value. The simulation results for CPC and CPC-D configurations
are shown in Figure 11b where the following process parameters used, seed mass 1 g, liquid phase
exchange 80 mL min−1, racemate mass 70 g. As can be seen, similar trends (i.e., drop in productivity)
are found with high values of α for the CPC and CPC-D configurations. The harvesting period for
the CPC-D configuration has also reduced significantly. However, it is to be noted that a higher
value of α = 100 is used for the CPC configuration in order to demonstrate the effect of nucleation
parameter, as α = 10 did not have any noticeable effect . This is because the supersatuation plays
an important role in nucleation rate, and in the CPC configuration there are no provisions for the
continuous supply of feed slurry or selective dissolution of racemate to compensate for the consumed
supersaturation for which both the growth and nucleation rate processes compete. Thus, the effect of
the increased value of nucleation kinetic parameters is less prominent for the CPC configuration. For a
crystallization system with high nucleation rate, a larger seed mass can be useful in promoting growth
and suppressing nucleation.
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Figure 11. Simulation results showing the effect of nucleation kinetic parameters on productivity
in Tank 1 for various configurations. (a) Results for the coupled preferential crystallization in
MSMPR crystallizers (CPC-MSMPR) with incremental values of α; (b) results for coupled preferential
crystallization (CPC) and coupled preferential crystallization-dissolution (CPC-D) configurations.
The scaling factor α is used to modify the kinetic parameters. With higher nucleation rate (i.e., higher
value of α), the purity of the product can go below the cut-off purity of eeS = 99% earlier, thus affecting
the productivity.
5. Conclusions
Preferential crystallization in vessels coupled via liquid phase exchange is an attractive means
for chiral resolution for conglomerate-forming systems. There are various process configurations
available for such crystallizations, e.g., batch coupled preferential crystallization (CPC), batch coupled
preferential crystallization-dissolution (CPC-D) and coupled preferential crystallization in MSMPR
crystallizers (CPC-MSMPR). In this work, first, we investigate the effect of various process parameters
on the productivity and yield of the various process configurations with particular focus on the recently
proposed CPC-MSMPR. This study is based on process simulation using experimentally verified kinetic
parameters from the literature. We then compare the performances of these configurations in terms of
productivity and yield. It is found that the productivity of CPC-MSMPR configuration increases as the
feed flow rate increases up to about 80 mL min−1. Beyond this flow rate, the increment in productivity
is marginal. This phenomena is the result of interplay between system kinetics (nucleation and growth
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rates) and the residence time of the process. Conversely, the yield of CPC-MSMPR configuration
decreases as the feed flow rate increases. Such observations can be attributed to the fact that high flow
rate leads to smaller residence time, and the slurry has less time to crystallize. The similar trends are
observed when the effect of liquid phase exchange is investigated. It is found that productivity of
CPC-MSMPR increases up to an exchange rate of 80 mL min−1, beyond which the return on increased
exchanged rate is very limited, while yield decreases with the increase of exchange rate. In the case
of the seed mass, it is found that both the productivity and yield increase with the increase of the
seed mass as it provides more crystal surface area for the solute molecules in the solution to attach.
However, for the CPC and CPC-D configurations, the effect of seed mass is found to be insignificant
as the driving force (supersaturation) becomes similar after some time in these batch configurations.
A study on the influence of racemic mass in Tank 2 for CPC-D configuration is also performed. As the
mass is increased, the productivity increases. However, the time period during which the product
crystal has to be collected (after the counter enantiomer dissolves in Tank 2 and before the appearance
of counter enantiomer in Tank 1 so that eeS ≥ 99% is maintained in both tanks) narrows down.
Thus, one needs to choose the mass of the racemic solid such that productivity can be maximized
while the harvest period is long enough for collecting product crystals. Next, the performances of
all the process configurations in terms of productivity and yield are compared. The CPC-MSMPR
configuration is found to be the most productive among the three configurations, however, with lowest
yield. Like many other engineering problems, here is a trade-off relationship between productivity
and yield. Nonetheless, based on the priority one can choose appropriate process parameters that
serve the required productivity and yield as closely as possible. Moreover, the provision of recycling
the solution from product stream to the feed after racemization can be employed to increase the overall
yield. Finally, the effect of a growth kinetics parameter is studied to investigate how the systems with
high nucleation rates influence the performances of various crystallizer configurations. It is found that
the higher nucleation rate of the counter enantiomer can lead to the loss of productivity due to the
drop in purity of the product crystals. However, the CPC configuration is found to be less affected as
the supersaturation in this configuration is usually lower due to the absence of feed stream.
The insights obtained in these results can be useful in designing a particular process configuration
or improving the existing one by manipulating the appropriate process parameters. The presented
results will also be helpful in choosing suitable process configuration. For instance, when a continuous
supply of pure enantiomers is required, CPC-MSMPR configuration will be preferred. Conversely,
if there is no provision for recycle and the separation yield is more important, then the CPC-D
configuration will be preferred. Moreover, the analysis presented will be useful in deciding the
appropriate feed flow rate, liquid phase exchange rate, and seed mass at the design stage of the process
so that the performance of the process can be improved in terms productivity, purity, and yield.
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Appendix. Model Parameters
Table A1. Kinetic and simulation parameters for the ternary system DL-threonine/H2O [10,11].
CSD: crystal size distribution.
Parameter Symbol Value Units
constant for density K1 1.00023× 10−3 m3 kg−1
constant for density K2 4.68× 10−9 m3 (kg ◦C)−1
constant for density K3 0.3652× 10−3 m3 kg−1
volume shape factor kv 0.1222 -
density of solid threonine ρs 1250 kg m−3
ideal gas constant Rg 8.314 J (K mol)−1
activation energy for growth EA,g 7.55× 104 J mol−1
activation energy for secondary nucleation EA,bsec 6.38× 104 J mol−1
dissolution rate constant kdiss 3× 10−5 m s−1
growth rate constant kg,e f f 1.24× 107 m s−1
growth exponent g 1.19 -
growth parameter (size-dependent term) aASL 2× 104 m−1
growth exponent (size-dependent term) γ −0.4 -
secondary nucleation rate constant kbsec,e f f 3.97× 1024 m−3 s−1
exponent for third moment nµ3 3.0258 -
secondary nucleation exponent bsec 4.8 -
primary nucleation rate constant knuc 1000 s−1
primary nucleation exponent bnuc 1 -
nucleation induction time tind 7200 s
slope of sigmoidal function φ 0.01 -
solubility parameter msol 1.2× 10−3 ◦C
solubility parameter bsol 0.059013 -
solubility parameter a1sol −0.0780 -
solubility parameter a2sol −0.1043 -
mean seed size of enantiomer E1 (L-threonine) Lmean,E1 27,95 µm
standard deviation of seed CSD σln,E1 0.3, 0.34 -
mean size of racemate Lmean,rac 9 µm
standard deviation of racemate CSD σln,rac 0.5 -
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